findmyKOL
Clinical trialNCT03499964Active, not recruitingInterventional

ROBUST III- Re-Establishing Flow Via Drug Coated Balloon For The Treatment Of Urethral Stricture Disease

SponsorUrotronic Inc.Enrollment127Urethral Stricture
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

ROBUST III is a prospective, multi-center, randomized controlled adaptive sample size clinical trial to establish the safety and effectiveness for the Optilume Stricture Drug Coated Balloon (DCB).
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

22 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada
  • Royal Victoria Hospital, Glen Site

    Montreal, Quebec, Canada

United States
  • Academic Urology and Urogynecology of Arizona

    Phoenix, Arizona, United States

  • Arkansas Urology

    Little Rock, Arkansas, United States

  • Advanced Urology Institute

    Daytona Beach, Florida, United States

  • University of Iowa

    Iowa City, Iowa, United States

  • Chesapeake Urology Research

    Annapolis, Maryland, United States

  • Chesapeake Urology

    Hanover, Maryland, United States

  • University of Minnesota Department of Urology

    Minneapolis, Minnesota, United States

  • Mayo Clinic

    Rochester, Minnesota, United States

  • Minnesota Urology

    Woodbury, Minnesota, United States

  • Adult & Pediatric Urology, Pc

    Omana, Nebraska, United States

  • New Jersey Urology

    Voorhees Township, New Jersey, United States

  • Western New York Urology Associates

    Cheektowaga, New York, United States

  • Columbia University Medical Center/new York-Presbyterian Hospital

    New York, New York, United States

  • Iris Cantor Men'S Health Center

    New York, New York, United States

  • Integrated Medical Professionals Obp

    North Hills, New York, United States

  • Carolina Urology Partners

    Concord, North Carolina, United States

  • Oregon Urology Institute

    Springfield, Oregon, United States

  • Ut Southwestern

    Dallas, Texas, United States

  • Urology San Antonio

    San Antonio, Texas, United States

  • Urology of Virginia

    Virginia Beach, Virginia, United States

  • University of Washington Harborview Medical Center

    Seattle, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
22 Jun 2018
Primary completion
10 Dec 2020
Completion
31 Aug 2026
Last update posted
19 May 2026
Registered enrollment
127
Registry id
NCT03499964
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.